Lattice Services
Develops medical-grade 3D printing filaments and R&D services for healthcare, enabling the production of resorbable implants and skin-contact devices with ISO 13485 compliance.
- CEO / Founder
- Julien Payen
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- €10.3M
- Latest Round
- Series A
- Key Investors
- Finovam Gestion, IRD, Nord France Amorçage, Re-Source Capital, Business Angels
Technology & Products
Key Products
Resorbable and implantable filaments; Skin-contact filaments; Loaded filaments for technical applications; Custom extrusion services; Material characterization services; Prototyping and industrialization support
Technological Advantage
The company leverages a proprietary filament extrusion process for medical-grade polymers, verified by its ISO 13485:2016 certification and its role in developing the MATTISSE bioresorbable breast reconstruction implant.
Differentiation
Value Proposition
Reduces R&D risk and time-to-market for medical device manufacturers by providing certified medical-grade materials and end-to-end industrialization support in a clean-room environment.
How They Differentiate
Differentiates through a specialized focus on implantable biomaterials and a service model that covers the entire medical device value chain, including regulatory and material characterization expertise.
Market & Competition
Target Customers
Healthcare companies and R&D projects integrating additive manufacturing into medical device development.
Industry Verticals
Medical
Competitors
Evonik (RESOMER filaments), Kumovis (3D Systems), 3D4Med
Growth & Milestones
Growth Metrics
Raised €8M Series A in 2022 to industrialize production; ISO 13485 certified for medical device manufacturing; expanded product line to include PCL, PLA, and custom resorbable copolymers.
Major Milestones
2020: Created as a dedicated brand within Lattice Medical to externalize filament expertise; Achieved ISO 13485:2016 certification for medical device quality management; Established a 3D printing farm in a clean-room environment; Supported the development and clinical trials of the MATTISSE bioresorbable implant
Notable Customers
CHRU de Lille, Inserm (French National Institute of Health and Medical Research)